Equities Analysts Set Expectations for ABOS FY2025 Earnings
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Free Report) – Equities researchers at Cantor Fitzgerald dropped their FY2025 earnings per share (EPS) estimates for shares of Acumen Pharmaceuticals in a report released on Thursday, May 15th. Cantor Fitzgerald analyst P. Stavropoulos now expects that the company will post earnings per share of ($1.92) for the year, down […]
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Free Report) – Equities researchers at Cantor Fitzgerald dropped their FY2025 earnings per share (EPS) estimates for shares of Acumen Pharmaceuticals in a report released on Thursday, May 15th. Cantor Fitzgerald analyst P. Stavropoulos now expects that the company will post earnings per share of ($1.92) for the year, down […]
